Neuronal Death/Survival Signaling Pathways in Cerebral Ischemia

NeuroRx

Volumn 1, Issue 1, 2004, Pages 17-25

  Sugawara, Taku ^a   Fujimura, Miki ^a   Noshita, Nobuo ^a   Kim, Gyung Whan ^a   Saito, Atsushi ^a   Hayashi, Takeshi ^a   Narasimhan, Purnima ^a   Maier, Carolina M ^a   Chan, Pak H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

apoptosis; Cerebral ischemia; oxidative stress; signaling pathway

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; LIPID; NUCLEIC ACID; OXYGEN RADICAL; PROTEIN; PROTEIN BAD; SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL SURVIVAL; ENZYME METABOLISM; GENETIC MANIPULATION; HUMAN; HYPOXIA; MITOCHONDRION; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; REOXYGENATION; REPERFUSION; SIGNAL TRANSDUCTION; STROKE; ANIMAL; BRAIN; CELL DEATH; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; HUMANS; NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 7644238227     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1602/neurorx.1.1.17     Document Type: Article

References (103)

1. Chan P. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21 (2001) 2-14
2. Chan P. Oxygen radicals in focal cerebral ischemia. Brain Pathol 4 (1994) 59-65
3. Lewen A., Matz P., and Chan P. Free radical pathways in CNS injury. J Neurotrauma 17 (2000) 871-890
4. Sugawara T., Lewen A., Gasche Y., Yu F., and Chan P. Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J 16 (2002) 1997-1999
5. Liu R., Althaus J., Ellerbrock B., Becker D., and Gurney M. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 44 (1998) 763-770
6. White B., Sullivan J., DeGracia D., O'Neil B., Neumar R., Grossman L., et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179 (2000) 1-33
7. Fujimura M., Morita-Fujimura Y., Noshita N., Sugawara T., Kawase M., and Chan P. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J Neurosci 20 (2000) 2817-2824
8. Noshita N., Sugawara T., Hayashi T., Lewen A., Omar G., and Chan P. Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J Neurosci 22 (2002) 7923-7930
9. Sugawara T., Fujimura M., Morita-Fujimura Y., Kawase M., and Chan P. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J Neurosci 19 RC39 (1999) 1-6
10. Sugawara T., Noshita N., Lewen A., Gasche Y., Ferrand-Drake M., Fujimura M., et al. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci 22 (2002) 209-217
11. Saito A., Hayashi T., Okuno S., Ferrand-Drake M., and Chan P. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. J Neurosci 23 (2003) 1710-1718
12. Boyer P., Chance B., Ernster L., Mitchell P., Racker E., and Slater E. Oxidative phosphorylation and photophosphorylation. Annu Rev Biochem 46 (1977) 955-1026
13. Fujimura M., Morita-Fujimura Y., Murakami K., Kawase M., and Chan P. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 18 (1998) 1239-1247
14. Perez-Pinzon M., Xu G., Born J., Lorenzo J., Busto R., Rosenthal M., et al. Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J Cereb Blood Flow Metab 19 (1999) 39-43
15. Ankarcrona M. Glutamate induced cell death: apoptosis or necrosis?. Prog Brain Res 116 (1998) 265-272
16. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92 (1995) 7162-7166
17. Green D., and Reed J. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
18. Kuida K., Haydar T., Kuan C., Gu Y., Taya C., Karasuyama H., et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94 (1998) 325-337
19. Li P., Nijhawan D., Budihardjo I., Srinivasula S., Ahmad M., Alnemri E., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
20. Yoshida H., Kong Y., Yoshida R., Elia A., Hakem A., Hakem R., et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94 (1998) 739-750
21. Zou H., Henzel W., Liu X., Lutschg A., and Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 (1997) 405-413
22. Slee E., Harte M., Kluck R., Wolf B., Casiano C., Newmeyer D., et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144 (1999) 281-292
23. Chen J., Nagayama T., Jin K., Stetler R., Zhu R., Graham S., et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 18 (1998) 4914-4928
24. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K., et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 18 (1998) 3659-3668
25. Kang S., Wang S., Hara H., Peterson E., Namura S., Amin-Hanjani S., et al. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 149 (2000) 613-622
26. Endres M., Wang Z., Namura S., Waeber C., and Moskowitz M. Ischemic brain injury is mediated by the activation of poly(ADP- ribose)polymerase. J Cereb Blood Flow Metab 17 (1997) 1143-1151
27. Eliasson M., Huang Z., Ferrante R., Sasamata M., Molliver M., Snyder S., et al. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci 19 (1999) 5910-5918
28. Deveraux Q., and Reed J. IAP family proteins-suppressors of apoptosis. Genes Dev 13 (1999) 239-252
29. Miller L. An exegesis of IAPs: salvation and surprises from BIR motifs. Trends Cell Biol 9 (1999) 323-328
30. Chai J., Du C., Wu J., Kyin S., Wang X., and Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406 (2000) 855-862
31. Yuan J., and Yankner B. Apoptosis in the nervous system. Nature 407 (2000) 802-809
32. Shi Y. A structural view of mitochondria-mediated apoptosis. Nat Struct Biol 8 (2001) 394-401
33. Merry D., and Korsmeyer S. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20 (1997) 245-267
34. Martinou J., Dubois-Dauphin M., Staple J., Rodriguez I., Frankowski H., Missotten M., et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13 (1994) 1017-1030
35. Plesnila N., Zinkel S., Le D., Amin-Hanjani S., Wu Y., Qiu J., et al. BID mediates neuronal cell death after oxygen/glucose deprivation and focal cerebral ischemia. Proc Natl Acad Sci USA 98 (2001) 15318-15323
36. Hata R., Gillardon F., Michaelidis T., and Hossmann K. Targeted disruption of the bcl-2 gene in mice exacerbates focal ischemic brain injury. Metab Brain Dis 14 (1999) 117-124
37. Hengartner M. The biochemistry of apoptosis. Nature 407 (2000) 770-776
38. Li H., Zhu H., Xu C., and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 (1998) 491-501
39. Rosenbaum D., Gupta G., D'Amore J., Singh M., Weidenheim K., Zhang H., et al. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J Neurosci Res 61 (2000) 686-692
40. Jin K., Graham S., Mao X., Nagayama T., Simon R., and Greenberg D. Fas (CD95) may mediate delayed cell death in hippocampal CA1 sector after global cerebral ischemia. J Cereb Blood Flow Metab 21 (2001) 1411-1421
41. Bruce A., Boling W., Kindy M., Peschon J., Kraemer P., Carpenter M., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2 (1996) 788-794
42. Yang E., Zha J., Jockel J., Boise L., Thompson C., and Korsmeyer S. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80 (1995) 285-291
43. L. Cell 87 (1996) 619-628
44. Gonzalez-Zulueta M., Feldman A., Klesse L., Kalb R., Dillman J., Parada L., et al. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 97 (2000) 436-441
45. Cardone M., Roy N., Stennicke H., Salvesen G., Franke T., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
46. Brunet A., Bonni A., Zigmond M., Lin M., Juo P., Hu L., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
47. Raingeaud J., Gupta S., Rogers J., Dickens M., Han J., Ulevitch R., et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270 (1995) 7420-7426
48. Boulton T., Nye S., Robbins D., Ip N., Radziejewska E., Morgenbesser S., et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65 (1991) 663-675
49. Avruch J., Zhang X., and Kyriakis J. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 19 (1994) 279-283
50. Frodin M., and Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151 (1999) 65-77
51. Zhu Y., Yang G., Ahlemeyer B., Pang L., Che X., Culmsee C., et al. Transforming growth factor-β1 increases Bad phosphorylation and protects neurons against damage. J Neurosci 22 (2002) 3898-3909
52. Lizcano J., Morrice N., and Cohen P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J 349 (2000) 547-557
53. Kimura S., Uchiyama S., Takahashi H., and Shibuki K. cAMP-dependent long-term potentiation of nitric oxide release from cerebellar parallel fibers in rats. J Neurosci 18 (1998) 8551-8558
54. Kontos H., and George E. Brown Memorial Lecture: oxygen radicals in cerebral vascular injury. Circ Res 57 (1985) 508-516
55. Siesjo B., Agardh C., and Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1 (1989) 165-211
56. Boveris A., and Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134 (1973) 707-716
57. Marklund S. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 79 (1982) 7634-7638
58. Chan P., Kinouchi H., Epstein C., Carlson E., Chen S., Imaizumi S., et al. Role of superoxide dismutase in ischemic brain injury: reduction of edema and infarction in transgenic mice following focal cerebral ischemia. Prog Brain Res 96 (1993) 97-104
59. He Y., Hsu C., Ezrin A., and Miller M. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. Am J Physiol (Lond) 265 (1993) H252-H256
60. Chan P., Longar S., and Fishman R. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 21 (1987) 540-547
61. Imaizumi S., Woolworth V., Fishman R., and Chan P. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 21 (1990) 1312-1317
62. Chan P., Epstein C., Kinouchi H., Kamii H., Imaizumi S., Yang G., et al. SOD-1 transgenic mice as a model for studies of neuroprotection in stroke and brain trauma. Ann NY Acad Sci 738 (1994) 93-103
63. Kinouchi H., Epstein C., Mizui T., Carlson E., Chen S., and Chan P. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA 88 (1991) 11158-11162
64. Chan P., Kawase M., Murakami K., Chen S., Li Y., Calagui B., et al. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci 18 (1998) 8292-8299
65. Murakami K., Kondo T., Epstein C., and Chan P. Overexpression of CuZn-superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice. Stroke 28 (1997) 1797-1804
66. Kawase M., Murakami K., Fujimura M., Morita-Fujimura Y., Gasche Y., Kondo T., et al. Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke 30 (1999) 1962-1968
67. Kondo T., Reaume A., Huang T.-T., Carlson E., Murakami K., Chen S., et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 17 (1997) 4180-4189
68. Kondo T., Reaume A., Huang T.-T., Murakami K., Carlson E., Chen S., et al. Edema formation exacerbates neurological and histological outcomes after focal cerebral ischemia in CuZn-superoxide dismutase gene knockout mutant mice. Acta Neurochir Suppl 70 (1997) 62-64
69. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S., et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18 (1998) 205-213
70. Fujimura M., Morita-Fujimura Y., Kawase M., Copin J.-C., Calagui B., Epstein C., et al. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome c and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci 19 (1999) 3414-3422
71. Keller J., Kindy M., Holtsberg F., St Clair D., Yen H., Germeyer A., et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18 (1998) 687-697
72. Sheng H., Bart R., Oury T., Pearlstein R., Crapo J., and Warner D. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience 88 (1999) 185-191
73. Sheng H., Brady T., Pearlstein R., Crapo J., and Warner D. Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci Lett 267 (1999) 13-16
74. Sheng H., Kudo M., Mackensen G., Pearlstein R., Crapo J., and Warner D. Mice overexpressing extracellular superoxide dismutase have increased resistance to global cerebral ischemia. Exp Neurol 163 (2000) 392-398
75. de Haan J., Bladier C., Griffiths P., Kelner M., O'Shea R., Cheung N., et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem 273 (1998) 22528-22536
76. Weisbrot-Lefkowitz M., Reuhl K., Perry B., Chan P., Inouye M., and Mirochnitchenko O. Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Mol Brain Res 53 (1998) 333-338
77. Crack P., Taylor J., Flentjar N., de Haan J., Hertzog P., Iannello R., et al. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem 78 (2001) 1389-1399
78. Crack P., Taylor J., de Haan J., Kola I., Hertzog P., and Iannello R. Glutathione peroxidase-1 contributes to the neuroprotection seen in the superoxide dismutase-1 transgenic mouse in response to ischemia/reperfusion injury. J Cereb Blood Flow Metab 23 (2003) 19-22
79. Kitagawa K., Matsumoto M., Tsujimoto Y., Ohtsuki T., Kuwabara K., Matsushita K., et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 29 (1998) 2616-2621
80. Wiessner C., Allegrini P., Rupalla K., Sauer D., Oltersdorf T., McGregor A., et al. Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neurosci Lett 268 (1999) 119-122
81. de Bilbao F., Guarin E., Nef P., Vallet P., Giannakopoulos P., and Dubois-Dauphin M. Cell death is prevented in thalamic fields but not in injured neocortical areas after permanent focal ischaemia in mice overexpressing the anti-apoptotic protein Bcl-2. Eur J Neurosci 12 (2000) 921-934
82. Hara H., Fink K., Endres M., Friedlander R., Gagliardini V., Yuan J., et al. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J Cereb Blood Flow Metab 17 (1997) 370-375
83. Friedlander R., Gagliardini V., Hara H., Fink K., Li W., MacDonald G., et al. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 185 (1997) 933-940
84. Schielke G., Yang G., Shivers B., and Betz A. Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice. J Cereb Blood Flow Metab 18 (1998) 180-185
85. Liu X., Kwon D., Schielke G., Yang G., Silverstein F., and Barks J. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 19 (1999) 1099-1108
86. Eliasson M., Sampei K., Mandir A., Hurn P., Traystman R., Bao J., et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3 (1997) 1089-1095
87. Goto S., Xue R., Sugo N., Sawada M., Blizzard K., Poitras M., et al. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 33 (2002) 1101-1106
88. Gary D., Bruce-Keller A., Kindy M., and Mattson M. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18 (1998) 1283-1287
89. Crumrine R., Thomas A., and Morgan P. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 14 (1994) 887-891
90. Chan P., Kamii H., Yang G., Gafni J., Epstein C., Carlson E., et al. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport 5 (1993) 293-296
91. Yang G., Chan P., Chen J., Carlson E., Chen S., Weinstein P., et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25 (1994) 165-170
92. Kamii H., Kinouchi H., Sharp F., Koistinaho J., Epstein C., and Chan P. Prolonged expression of hsp70 mRNA following transient focal cerebral ischemia in transgenic mice overexpressing CuZn-superoxide dismutase. J Cereb Blood Flow Metab 14 (1994) 478-486
93. Kamii H., Kinouchi H., Sharp F., Epstein C., Sagar S., and Chan P. Expression of c-fos mRNA after a mild focal cerebral ischemia in SOD-1 transgenic mice. Brain Res 662 (1994) 240-244
94. Kondo T., Murakami K., Honkaniemi J., Sharp F., Epstein C., and Chan P. Expression of hsp70 mRNA is induced in the brain of transgenic mice overexpressing human CuZn-superoxide dismutase following transient global cerebral ischemia. Brain Res 737 (1996) 321-326
95. Kamii H., Mikawa S., Murakami K., Kinouchi H., Yoshimoto T., Reola L., et al. Effects of nitric oxide synthase inhibition on brain infarction in SOD- 1-transgenic mice following transient focal cerebral ischemia. J Cereb Blood Flow Metab 16 (1996) 1153-1157
96. Ditelberg J., Sheldon R., Epstein C., and Ferriero D. Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Pediatr Res 39 (1996) 204-208
97. Fullerton H., Ditelberg J., Chen S., Sarco D., Chan P., Epstein C., et al. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 44 (1998) 357-364
98. Fujimura M., Morita-Fujimura Y., Narasimhan P., Copin J.-C., Kawase M., and Chan P. Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 30 (1999) 2408-2415
99. Huang C.-Y., Fujimura M., Noshita N., Chang Y.-Y., and Chan P. SOD1 down-regulates NF-κB and c-myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21 (2001) 163-173
100. Huang C.-Y., Fujimura M., Chang Y.-Y., and Chan P. Overexpression of copper-zinc superoxide dismutase attenuates acute activation of activator protein-1 after transient focal cerebral ischemia in mice. Stroke 32 (2001) 741-747
101. Fujimura M., Morita-Fujimura Y., Copin J.-C., Yoshimoto T., and Chan P. Reduction of copper, zinc-superoxide dismutase in knockout mice does not affect edema or infarction volumes and the early release of mitochondrial cytochrome c after permanent focal cerebral ischemia. Brain Res 889 (2001) 208-213
102. Noshita N., Sugawara T., Fujimura M., Morita-Fujimura Y., and Chan P. Manganese superoxide dismutase affects cytochrome c release and caspase-9 activation after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21 (2001) 557-567
103. Kim G., Kondo T., Noshita N., and Chan P. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 33 (2002) 809-815